the microsampling blog / COVID-19

In the US, use of the Mitra device with blood is limited to research and non-diagnostic applications. In the US, the device is not for use with saliva samples intended for clinical DNA testing. In many countries outside the US, the Mitra device is approved as a remote blood sample collection device for some clinical applications, as referenced in some content.

by Christa Nuber | 6 min read

In early May 2021, the Centers for Disease Control and Protection (CDC), relaxed their face masking and social distancing restrictions for people who were fully vaccinated against SARS-CoV-2, the virus …

Read Story
Topics:

by Neoteryx | 2 min read

Biological specimens like saliva, blood, or urine are often collected for use in routine patient monitoring and population surveys. Population surveys are essential because they provide current, detailed health and …

Read Story
Topics:

by James Rudge, PhD, Technical Director, Neoteryx | 15 min read

When the COVID-19 pandemic hit in early 2020, people needed to shelter and isolate, whole countries were locked down and movement of individuals was reduced to an absolute minimum. For many, there was a temporary respite during the summer when infections dropped significantly, and …

Read Story
Topics:

Learn about insights, research, case studies, and tutorials on integrating remote specimen collection, microsampling, and more!

search our blog

social media

subscribe to the blog